Relapsing fever

Alternative Names:
Tick-borne relapsing fever, Louse-borne relapsing fever

Treatment:
The mainstay of treatment is antibiotics -- primarily tetracycline, doxycycline, or penicillin.

Expectations (prognosis):
The mortality (death) rate for untreated louse-borne relapsing fever ranges from 10-70% and from 4-10% in tick-borne relapsing fever. With early treatment, the mortality rate is reduced to 2-5%. Individuals with coma, myocarditis, liver dysfunction, and pneumonia are at higher risk of death.

Complications:
  • neurologic complications: seizures, weakness, facial droop, meningitis, coma
  • myocarditis -- may lead to arrhythmias
  • pneumonia
  • liver dysfunction
  • diffuse bleeding
  • Jarisch - Herxheimer's reaction during antibiotic therapy may be fatal in some cases


Calling your health care provider:
Notify your medical provider if you are a returning traveler and you develop fever -- there are many different possible infections that will need to be investigated in a timely manner.


Review Date: 1/3/2003
Reviewed By: Camille Kotton, M.D., Infectious Diseases Division, Massachusetts General Hospital and Brigham and Women's Hospital, Boston, MA. Review provided by VeriMed Healthcare Network.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.